Quillivant ER Chewable Tablets 30 mg

Quillivant ER Chewable Tablets 30 MG contain methylphenidate hydrochloride, an extended-release medication used for attention deficit hyperactivity disorder (ADHD). These chewable tablets offer a convenient oral option for managing ADHD symptoms.

Quillivant ER Chewable Tablets 30 MG are primarily used for the treatment of ADHD. Methylphenidate hydrochloride, the active ingredient, is commonly prescribed to improve focus, reduce impulsivity, and manage hyperactivity. These tablets are designed for extended-release, providing sustained symptom control throughout the day. Quillivant ER Chewable Tablets 30 MG are often considered when other forms of medication are not suitable or convenient.

Common effects of Quillivant ER Chewable Tablets 30 MG may include increased alertness, improved concentration, and reduced hyperactivity. Some individuals may experience mild side effects such as decreased appetite, trouble sleeping, or stomach upset. These effects can vary widely among users and are not experienced by everyone.

Quillivant ER Chewable Tablets 30 MG should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. These tablets should be stored in a cool, dry place away from children and pets. Always consult a healthcare provider before starting or stopping any medication.

Quillivant ER Chewable Tablets 30 MG may interact with certain medications, including other stimulants, antidepressants, and blood pressure medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication.